Cyrielle Billon

Cyrielle Billon is a research faculty member in the Department of Pharmaceutical and Administrative Sciences at the University of Health Sciences and Pharmacy (UHSP). Her research focuses on nuclear receptor pharmacology, particularly estrogen-related receptors (ERRs), and their role in metabolism, circadian rhythms, and disease pathophysiology.

Her primary research interests include:

• Nuclear receptor pharmacology and signaling pathways
• Development of synthetic ligands for ERRs as potential therapeutics
• Interactions between circadian biology and metabolic regulation
• Therapeutic applications for metabolic disorders and cardiovascular diseases

Dr. Billon's publication record demonstrates significant contributions to ERR pharmacology, with recent work on SLU-PP-332 showing how ERR agonists can enhance exercise capacity and induce metabolic improvements. Her research spans multiple disease areas including metabolic syndrome, atherosclerosis, and cancer metabolism.

She maintains active collaborations with researchers at Washington University School of Medicine in St. Louis and other institutions, contributing to a robust publication record with multiple high-impact papers between 2020-2024. Her work has been cited extensively, reflecting its significance in the field of nuclear receptor research.